Bioresorbable Stents

Bioresorbable Stents

Global Bioresorbable Stents Market to Reach $692 Million by 2027

Growth in the global market is set to be fueled by increasing prevalence of cardiovascular diseases such as peripheral artery and coronary artery diseases, increasing elderly population, and fast increasing obese population. Additional growth factors include an increase in number of PCI procedures performed each year, more patients favoring minimally invasive therapies, higher adoption of these stents by patients and physicians alike, and greater number of clinical trials evaluating the use of bioabsorbable stents. The popularity of bioabsorbable stents is influenced by the elimination of the need to perform stent-in-stent procedures, elimination of the requirement for dual anti-platelet therapies, higher degree of effectiveness in treating coronary artery diseases, and the possibility of achieving accurate stent placement as well as cost-effectiveness of the treatment.

In the changed post COVID-19 business landscape, global market for Bioresorbable Stents estimated at US$317 Million in the year 2020, is projected to reach a revised size of US$692 Million by 2027, growing at a CAGR of 11.8% over the analysis period 2020-2027. Polymer-Based, one of the segments analyzed in the report, is projected to record more than 10% CAGR and reach more than US$450 Million by the end of the analysis period.

Select Competitors (Total 25 Featured) -

  • Abbott Laboratories
  • Arterius Limited
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corp.
  • Kyoto Medical Planning Co., Ltd.
  • LEPU MEDICAL TECHNOLOGY CO., LTD.
  • Meril Life Sciences Pvt. Ltd.
  • REVA Medical, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Bioresorbable Stents – Global Key Competitors Percentage Market Share in 2022 (E)
Coronary Artery Disease (CAD) – A Perspective
Causes and Symptoms
Treatment Options for Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)
Coronary Stenting
Types of Coronary Stents
Bare Metal Stents (BMS)
Drug Eluting Stents (DES)
Bioresorbable Scaffolds
Design and Composition of Bioresorbable Scaffolds
Different Types of Bioresorbable Scaffolds
Metallic Bioresorbable Scaffolds
Polymer Bioresorbable Scaffolds
Degradation Period of Select Bioabsorbable Materials
Challenges
Clinical Characteristics of Various Coronary Stents
Other Treatment Options for Coronary Heart Disease
Coronary Artery Bypass Grafting (CABG)
Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
TransMyocardial Laser Revascularization (TMR)
Peripheral Arterial Disease: Understanding the Stealthy Peril
Treatment for PAD
Stenting- A Treatment Option for PAD
BioResorbable Stents – A Prelude
Bioresorbable Vascular Scaffolds: Advantages and Challenges
Bioresorbable Stents – A Revolutionary Technology, Riddled with Controversies
Abbott Stops Sales of the Once Promising ‘Absorb’ Bioresorbable Stents due to Adverse Events
Impact of Abbott’s Withdrawal of Absorb on the Bioresorbable Stent Industry
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Impact of COVID – 19 on Coronary Stents Market
Impact on Supply Chain
Impact of COVID-19 Outbreak on Elective Surgeries
Global Bioresorbable Stents Market Buckles under COVID-19 Strain
GLOBAL MARKET OVERVIEW
Global Bioresorbable Stents Set to Witness Growth in Future
Europe Dominates, Asia-Pacific Exhibits Fastest Growth
CAD Constitutes the Leading Application
Metallic Vs. Polymer-based Stents
Bioabsorbable Metallic Stents
Bioabsorbable Polymer Stents
Disappointing Results by Absorb to Increase Focus on Metallic Stents
Availability of Alternative Treatments – Hindrance to Market Growth
Market Challenges
MARKET OUTLOOK
Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents
The Future of BRS Technology
COMPETITION
Select Approved Bioresorbable Scaffolds
Select Bioresorbable Stents in Pipeline
Abbott Revives Bioresorbable Stent Clinical Trials to Evaluate New Esprit Scaffold
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Polymeric Resorbable Scaffolds Hold a Major Market Share
The Absorb BRS program
Desaminotyrosine Polycarbonate-based BRS
The FANTOM program
Magnesium-based BRS
The Magmaris program
Iron-based BRS
Global Menace of Coronary Artery Disease (CAD) – A Major Growth Driver
Global Annual Medical Cost of CVD in the United States: 2015-2030
Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Rising Middle Class Population Aids Growth
Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P
Rising Healthcare Expenditure: Opportunities in Store
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Risk of CAD in Obesity Offers Prospects for Coronary Stenting
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Diabetics at Higher Risk of Heart Diseases
TABLE 15: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
The Hypertension-Cholesterol Link to Drive Demand
Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
Metal Bioresorbable scaffolds Exhibit Improved Performance Compared to Polymer Stents
Metal Stents Vis-à-Vis Other Stents
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Bioresorbable Stents by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World 7-Year Perspective for Bioresorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027
TABLE 3: World Recent Past, Current & Future Analysis for Polymer-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 4: World 7-Year Perspective for Polymer-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 5: World Recent Past, Current & Future Analysis for Metal-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 6: World 7-Year Perspective for Metal-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Coronary Artery Disease/CAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World 7-Year Perspective for Coronary Artery Disease/CAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 9: World Recent Past, Current & Future Analysis for Peripheral Artery Disease/PAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 10: World 7-Year Perspective for Peripheral Artery Disease/PAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 12: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Cardiovascular Centers by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World 7-Year Perspective for Cardiovascular Centers by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
III. MARKET ANALYSIS
EUROPE
TABLE 15: Europe Recent Past, Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 16: Europe 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2021 & 2027
TABLE 17: Europe Recent Past, Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 18: Europe 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2021 & 2027
TABLE 19: Europe Recent Past, Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 20: Europe 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2021 & 2027
ASIA-PACIFIC
TABLE 21: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 22: Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2021 & 2027
TABLE 23: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 24: Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2021 & 2027
TABLE 25: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: Asia-Pacific 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2021 & 2027
REST OF WORLD
TABLE 27: Rest of World Recent Past, Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 28: Rest of World 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2021 & 2027
TABLE 29: Rest of World Recent Past, Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 30: Rest of World 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2021 & 2027
TABLE 31: Rest of World Recent Past, Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Rest of World 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 25

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings